Cara Therapeutics
CARA
$0.66
Share price
-4.20%
Change (1 day)
-84.22%
Change (1 year)
Categories
Cara Therapeutics (CARA) - Net assets
Net assets on the balance sheet as of December 2023 : $57.08 M
According to Cara Therapeutics
's latest financial reports the company has $57.08 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Cara Therapeutics - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $57.08 M | -64.05% |
| 2022-12-31 | $0.15 B | -30.21% |
| 2021-12-31 | $0.22 B | -8.63% |
| 2020-12-31 | $0.24 B | 33.36% |
| 2019-12-31 | $0.18 B | 39.72% |
| 2018-12-31 | $0.13 B | 53.99% |
| 2017-12-31 | $86.78 M | 71.08% |
| 2016-12-31 | $50.72 M | -51.71% |
| 2015-12-31 | $0.10 B | 103.33% |
| 2014-12-31 | $51.66 M | 348.81% |
| 2013-12-31 | $11.51 M | 371.96% |
| 2012-12-31 | $2.43 M | -60.04% |
| 2011-12-31 | $6.1 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 120,376.48% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | 156,312.37% | 🇺🇸 USA |
 Trevena TRVN | $3.54 M | -93.78% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $58.95 M | 3.28% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $14.1 M | -75.29% | 🇺🇸 USA |